Application Progress of Traditional Chinese Medicine as an Adjuvant Therapy for Cardiovascular and Cerebrovascular Diseases

Shuxiu Ding; Ruoqi Li; Yuxin Sun

doi:10.62051/pga7r342

Authors

Shuxiu Ding
Ruoqi Li
Yuxin Sun

DOI:

https://doi.org/10.62051/pga7r342

Keywords:

Traditional Chinese medicine, cardiovascular and cerebrovascular disease, adjuvant therapy.

Abstract

At present, CVDs are a crucial problem that has puzzled many researchers for a long period. It has a high fatality rate because it will cause many complications and adverse effects on metabolism. Many side effects of pharmaceutical drugs are very serious because the majority of medicine that treat CVDs are western medicines. Pathogenic factors could not be inhibited effectively and the appropriate target spot was not discovered. However, more and more new technologies and drugs have developed and improved in treating this disease. The combination of TCM and WM has profound prospects. Especially in the clinical treatments of CVDs, TCMs play a role as adjunctive drugs by promoting blood circulation and removing blood stasis. And it can be used for reducing the toxic and side effects of chemical medicines. This integrated method not only maintains the traditional theory and drugs such as herbal, animal and mineral materials but also improves therapeutic effects by combining WM and using advanced devices, artificial intelligence and Western dosage forms. These integrative methods can effectively improve the therapeutic effects and reduce the frequency of adverse effects. Scientists made great progress and achievements in this field. However, the specific mechanism of action of the compounds still needs to be explained deeply.

Downloads

Download data is not yet available.

References

[1] Lu Jingjing, Zhang Mingxue. Mechanism of action and clinical study of Salvia miltiorrhiza-safflower medicine on the treatment of cardiovascular and cerebrovascular diseases [J/OL]. Journal of Liaoning University of Traditional Chinese Medicine. Available from: https://link.cnki.net/urlid/21.1543.R.20240829.1042.004

[2] Jiao Panpan, Wu Suhui, Li Yanbing, Li Genlin. Herbal research of "ivy" and research progress of modern pharmacology [J/OL]. China Journal of Traditional Chinese Medicine.

[3] Dobos, G., Tao, I. The model of western integrative medicine: The role of Chinese medicine. Chin. J. Integr. Med., 2011, 17: 11-20.

[4] Sun, B., Liu, C., Li, Y., Huang, Q., Chu, X. An approach to co-medication mechanism mining of Chinese Materia Medica and western medicines based on complex networks with the multi-source heterogeneous information. Information Fusion, 2024, 102: 102081.

[5] Julian, D. G., Pocock, S. J. Effects of long-term use of cardiovascular drugs. The Lancet, 2015, 385: 325.

[6] Rossello, X., Pocock, S. J., Julian, D. G. Long-Term Use of Cardiovascular Drugs: Challenges for Research and for Patient Care. Journal of the American College of Cardiology, 2015, 66: 1273-1285.

[7] Tang Y, Bao J, Hu J, Liu L, Xu DY. Circular RNA in cardiovascular disease: Expression, mechanisms and clinical prospects. J Cell Mol Med, 2021, 25(4): 1817-1824.

[8] Jiang K, Xu Y, Wang D, Chen F, Tu Z, Qian J, Xu S, Xu Y, Hwa J, Li J, Shang H, Xiang Y. Cardioprotective mechanism of SGLT2 inhibitor against myocardial infarction is through reduction of autosis. Protein Cell, 2022, 13(5): 336-359.

[9] Li, D., Long, Y., Yu, S., Shi, A., Wan, J., Wen, J., Li, X., Liu, S., Zhang, Y., Li, N., Zheng, C., Yang, M., Shen, L. Research Advances in Cardio-Cerebrovascular Diseases of Ligusticum chuanxiong Hort. Frontiers in Pharmacology, 2022, 12.

[10] Guo Long, Xue ZJ, Zhang Dan, et al. Research progress on pharmacological activity of tanshinones in the treatment of cardiovascular and cerebrovascular diseases [J]. Asian-pacific Traditional Medicine, 2019, 15(2): 190-192.

[11] Zhao Yuhan, Xiao Guangxu, Fan Wen, et al. The mechanism of action and clinical study of Salvia miltiorrhiza Chuanxiong in the treatment of cardiovascular and cerebrovascular diseases [J]. Chinese Journal of Arteriosclerosis, 2022, 30(6): 461-469.

[12] Ge, Y.-R., Huan, N., Wang, C.-L., Wang, P.-L. Application Progress and Prospect of Herbal and Western Medicine Combined with Antiplatelet Therapy for Cardiovascular Events. Evidence-Based Complementary and Alternative Medicine: eCAM, 2021, 5563987.

[13] Xu. Roles of Chinese Medicine and Gut Microbiota in Chronic Constipation. Evidence-Based Complementary and Alternative Medicine. Available from: https://onlinelibrary.wiley.com/doi/full/10.1155/2019/9372563.

[14] Ren, W., et al. The Effect of Chinese Herbal Medicine Combined With Western Medicine on Vascular Endothelial Function in Patients With Hypertension: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Front. Pharmacol., 2020, 11: 823.

[15] Cheng, Y.-C., et al. Decreased stroke risk with combined traditional Chinese and western medicine in patients with ischemic heart disease: A real-world evidence. Medicine (Baltimore), 2020, 99: e22654.

[16] Frontiers. Chinese herbal injection for cardio-cerebrovascular disease: Overview and challenges. Available from: https://onlinelibrary.wiley.com